What is the Difference Between Lupus and Fibro?
At a Glance
Lupus is an autoimmune disease that causes systemic tissue inflammation and potential organ damage. Fibromyalgia is a chronic disorder of altered pain processing that causes widespread pain without tissue damage. While they share symptoms like severe fatigue, their treatments are entirely different.
In this answer
3 sections
The primary difference between systemic lupus erythematosus (lupus) and fibromyalgia is that lupus is an autoimmune disease that causes measurable tissue inflammation and potential organ damage, whereas fibromyalgia is a chronic condition causing widespread pain and fatigue without tissue inflammation. Because they share debilitating symptoms such as severe fatigue, brain fog, and body aches, they are frequently confused or misdiagnosed [1][2]. Both conditions also disproportionately affect women.
The Root Cause: Inflammation vs. Pain Processing
While the symptoms may feel similar, what happens inside your body is very different.
Systemic lupus erythematosus (SLE) is an autoimmune disease [2][3]. This means your immune system mistakenly attacks your body’s own healthy tissues, leading to systemic inflammation [4]. Over time, this inflammation can cause visible damage to joints, skin, and internal organs such as the kidneys or heart.
Fibromyalgia, on the other hand, is considered a disorder of nociplastic pain [5][2]. This means that the central nervous system processes pain signals abnormally, amplifying sensations of pain. While fibromyalgia causes very real and chronic widespread pain and extreme fatigue, it is not an autoimmune condition and does not cause tissue inflammation or damage to the organs [6][2].
How Doctors Tell the Difference
Because fatigue and joint pain are common to both conditions, doctors use a combination of physical examinations and specific diagnostic criteria to tell them apart [5].
- Blood Tests: Lupus is diagnosed using standardized classification criteria that rely heavily on specific blood markers [5][7]. The Antinuclear Antibody (ANA) test is usually positive in people with lupus [8]. However, a positive ANA test alone does not mean you have lupus—it can also be positive in healthy people or those with fibromyalgia [6][9]. To confirm lupus, doctors look for more specific markers like anti-dsDNA or changes in complement proteins that indicate active autoimmunity [10][4].
- Physical Symptoms: Lupus often presents with objective signs of inflammation. These include visibly swollen or warm joints, skin rashes (like a butterfly-shaped rash across the cheeks and nose), mouth sores, or unexplained fevers [5][6].
- Clinical Diagnosis: There are no specific blood tests for fibromyalgia. Instead, it is a clinical diagnosis. Doctors often use tools like the Widespread Pain Index (WPI) and Symptom Severity (SS) scales to evaluate the extent of pain in the muscles and soft tissues. This pain typically occurs without any visible swelling or clinical signs of autoimmunity [5][2].
When Lupus and Fibromyalgia Happen Together
These conditions are not mutually exclusive. Fibromyalgia is a very common comorbidity (a condition occurring at the same time) in people with systemic lupus erythematosus [11][12].
Having both conditions can complicate your diagnosis and medical care. The extreme pain and fatigue of fibromyalgia can easily mimic an active lupus flare, even when your actual inflammation levels are low [11][13]. This overlap can inflate standard disease activity scores, creating a disconnect between the intense symptom burden you feel and the objective signs of inflammation your doctor measures [14][15]. Patients who experience both conditions often report a significantly lower health-related quality of life compared to those living with lupus alone [16][17].
Why the Distinction Matters for Your Treatment
Understanding whether your pain is coming from lupus inflammation or fibromyalgia’s altered pain processing is critical because their treatments are completely different.
Treatments for lupus (such as corticosteroids and immunosuppressants) target the immune system to stop inflammation and prevent organ damage. However, these powerful medications will not relieve the non-inflammatory pain of fibromyalgia. Misattributing fibromyalgia pain to active lupus can lead to dangerous, unnecessary increases in toxic immunosuppressive medications. Conversely, fibromyalgia is typically managed with nervous system modulators, physical therapy, and specific pain management strategies—therapies that do not treat underlying lupus inflammation.
By tracking your specific symptoms (like noting whether you have visible joint swelling versus all-over muscle aches), you and your doctor can better identify which condition is flaring and tailor a specialized, multi-disciplinary treatment plan that effectively addresses both sources of your pain.
Common questions in this guide
Can you have both lupus and fibromyalgia at the same time?
How do doctors test for the difference between lupus and fibromyalgia?
Does a positive ANA test mean my pain is from lupus instead of fibromyalgia?
Why is it important to tell lupus and fibromyalgia apart?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How can we distinguish whether my current increase in pain and fatigue is due to a lupus flare-up or a fibromyalgia flare?
- 2.Do my current blood test results show specific markers for active lupus inflammation, beyond just a positive ANA?
- 3.Are there physical exams or imaging tests we can use to confirm whether my joint pain is caused by inflammation or by altered pain processing?
- 4.If I have both conditions, how should we adjust my treatment plan to address the non-inflammatory pain of fibromyalgia without unnecessarily increasing my immunosuppressive medications?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Patient-Reported Outcomes for Quality of Life in SLE: Essential in Clinical Trials and Ready for Routine Care.
Nguyen MH, Huang FF, O'Neill SG
Journal of clinical medicine 2021; (10(16)) doi:10.3390/jcm10163754.
PMID: 34442047 - 2
Identifying and Managing Nociplastic Pain in Individuals With Rheumatic Diseases: A Narrative Review.
Murphy AE, Minhas D, Clauw DJ, Lee YC
Arthritis care & research 2023; (75(10)):2215-2222 doi:10.1002/acr.25104.
PMID: 36785994 - 3
A Novel System to Categorize the Symptoms of Systemic Lupus Erythematosus.
Pisetsky DS, Clowse MEB, Criscione-Schreiber LG, Rogers JL
Arthritis care & research 2019; (71(6)):735-741 doi:10.1002/acr.23794.
PMID: 30354033 - 4
Systemic lupus erythematosus and immunodeficiency.
Sawada T, Fujimori D, Yamamoto Y
Immunological medicine 2019; (42(1)):1-9 doi:10.1080/25785826.2019.1628466.
PMID: 31204893 - 5
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.
Aringer M, Costenbader K, Daikh D, et al.
Annals of the rheumatic diseases 2019; (78(9)):1151-1159 doi:10.1136/annrheumdis-2018-214819.
PMID: 31383717 - 6
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus.
Nashi RA, Shmerling RH
Rheumatic diseases clinics of North America 2022; (48(2)):569-578 doi:10.1016/j.rdc.2022.02.012.
PMID: 35400379 - 7
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
Aringer M, Costenbader K, Daikh D, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(9)):1400-1412 doi:10.1002/art.40930.
PMID: 31385462 - 8
Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data.
Leuchten N, Hoyer A, Brinks R, et al.
Arthritis care & research 2018; (70(3)):428-438 doi:10.1002/acr.23292.
PMID: 28544593 - 9
Antinuclear antibody testing - misunderstood or misbegotten?
Pisetsky DS
Nature reviews. Rheumatology 2017; (13(8)):495-502 doi:10.1038/nrrheum.2017.74.
PMID: 28541299 - 10
Antinuclear antibody testing in a Turkish pediatrics clinic: is it always necessary?
Aygün E, Kelesoglu FM, Dogdu G, et al.
The Pan African medical journal 2019; (32()):181 doi:10.11604/pamj.2019.32.181.13793.
PMID: 31312295 - 11
The frequency of fibromyalgia in patients with systemic lupus erythematosus and associated factors: a systematic review and meta-analysis.
Mistry S, Daoud A, Magrey MN, Pamuk ON
Clinical rheumatology 2025; (44(1)):9-21 doi:10.1007/s10067-024-07188-9.
PMID: 39424681 - 12
Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus.
Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, et al.
Clinical and experimental rheumatology 2016; (34(2 Suppl 96)):S40-7.
PMID: 26575317 - 13
Fibromyalgia comorbidity in Systemic Lupus Erythematosus patients: assessing impact on quality of life.
Monteiro JAM, Gama ALH, Oliveira JCS, et al.
Advances in rheumatology (London, England) 2024; (64(1)):90 doi:10.1186/s42358-024-00432-5.
PMID: 39696564 - 14
Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
Elefante E, Tani C, Stagnaro C, et al.
Arthritis research & therapy 2020; (22(1)):241 doi:10.1186/s13075-020-02334-5.
PMID: 33054823 - 15
Functional Status Measures and Indices in Rheumatoid Arthritis: Comment on the Articles by Barber et al and England et al.
Schmukler J, Block JA, Pincus T, et al.
Arthritis care & research 2020; (72(8)):1185-1186 doi:10.1002/acr.24229.
PMID: 32339399 - 16
Impact of Systemic Lupus Erythematosus on Health-Related Quality of Life in Colombian Patients: A Cross-Sectional Analytical Study.
Fonseca-Zuluaga PA, Pérez-Ocampo J, Velásquez-Franco CJ, et al.
Patient preference and adherence 2025; (19()):1263-1272 doi:10.2147/PPA.S498414.
PMID: 40330536 - 17
Differences in quality of life determinants according to the presence of fibromyalgia in middle-aged female patients with systemic lupus erythematosus: a multicenter, cross-sectional, single-ethnicity cohort.
Moon SJ, Kang KY, Kwok SK, et al.
International journal of rheumatic diseases 2018; (21(6)):1173-1184 doi:10.1111/1756-185X.13320.
PMID: 29879313
This page explains the differences between lupus and fibromyalgia for educational purposes only. Always consult your healthcare provider or rheumatologist for an accurate diagnosis and personalized treatment plan.
Get notified when new evidence is published on Systemic lupus erythematosus.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.